Literature DB >> 26228883

Correlation of Asymmetry Indices Measured by Arterial Spin-Labeling MR Imaging and SPECT in Patients with Crossed Cerebellar Diaschisis.

K M Kang1, C-H Sohn2, B S Kim1, Y I Kim3, S H Choi4, T J Yun1, J-h Kim1, S-W Park5, G J Cheon3, M H Han4.   

Abstract

BACKGROUND AND
PURPOSE: Crossed cerebellar diaschisis, not only a secondary result of supratentorial infarction but also an indicator of clinical outcomes, has frequently been reported on PET and SPECT but has been rarely described with arterial spin-labeling MR imaging. The purpose of this study was to determine the ability of arterial spin-labeling MR imaging to evaluate crossed cerebellar diaschisis compared with that of SPECT. To our knowledge, this is the first study to validate arterial spin-labeling in crossed cerebellar diaschisis by using SPECT as a reference standard.
MATERIALS AND METHODS: This study included 16 patients in whom crossed cerebellar diaschisis was shown on SPECT and 10 control subjects in whom crossed cerebellar diaschisis was not shown on SPECT. During the qualitative analysis, asymmetric cerebellar perfusion on arterial spin-labeling was divided into 1 of the following 3 grades by 2 blinded observers: the affected cerebellum was isointense compared with the unaffected cerebellum (grade I), it was slightly hypointense (grade II), or it was markedly hypointense (grade III). In the quantitative analysis, asymmetry indices were calculated by using SPECT and arterial spin-labeling images. For statistical analysis, κ statistics, the interobserver correlation coefficient, the independent t test, Pearson correlation, and linear regression analysis were used.
RESULTS: Almost all the diagnoses of crossed cerebellar diaschisis on SPECT were noted on arterial spin-labeling in both qualitative and quantitative analyses with good interobserver agreement (κ = 0.961; interobserver correlation coefficient, 0.806). The mean asymmetry index of arterial spin-labeling (26.06 ± 9.00) was significantly larger than that for SPECT (15.28 ± 5.34; P < .001). There was a significant positive correlation between the asymmetry indices obtained for SPECT and those for arterial spin-labeling (r = 0.77 [95% CI, 0.443-0.916]; P < .001). The relationship of asymmetry indices between SPECT and arterial spin-labeling (x, y) was calculated as y = 6.2131 + 1.2986x (R(2) = 0.592; P < .001).
CONCLUSIONS: Arterial spin-labeling can be a noninvasive alternative to SPECT for evaluating crossed cerebellar diaschisis.
© 2015 by American Journal of Neuroradiology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26228883      PMCID: PMC7968766          DOI: 10.3174/ajnr.A4366

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  45 in total

1.  Ataxic hemiparesis from strategic frontal white matter infarction with crossed cerebellar diaschisis.

Authors:  Alexander C Flint; MaryAlice C Naley; Clinton B Wright
Journal:  Stroke       Date:  2005-11-23       Impact factor: 7.914

2.  Prognostic value of subacute crossed cerebellar diaschisis: single-photon emission CT study in patients with middle cerebral artery territory infarct.

Authors:  Masashi Takasawa; Manabu Watanabe; Shiro Yamamoto; Taku Hoshi; Tsutomu Sasaki; Kazuo Hashikawa; Masayasu Matsumoto; Naokazu Kinoshita
Journal:  AJNR Am J Neuroradiol       Date:  2002-02       Impact factor: 3.825

3.  Crossed cerebellar diaschisis after middle cerebral artery infarction.

Authors:  J De Reuck; D Decoo; I Lemahieu; K Strijckmans; P Goethals; G Van Maele
Journal:  Clin Neurol Neurosurg       Date:  1997-02       Impact factor: 1.876

4.  Validation studies of iodine-123-iodoamphetamine as a cerebral blood flow tracer using emission tomography.

Authors:  J H Greenberg; M Kushner; M Rango; A Alavi; M Reivich
Journal:  J Nucl Med       Date:  1990-08       Impact factor: 10.057

5.  Evaluation of crossed cerebellar diaschisis in 30 patients with major cerebral artery occlusion by means of quantitative I-123 IMP SPECT.

Authors:  N Miyazawa; K Toyama; A S Arbab; K Koizumi; T Arai; H Nukui
Journal:  Ann Nucl Med       Date:  2001-12       Impact factor: 2.668

6.  Depressed cerebellar glucose metabolism in supratentorial tumors.

Authors:  N J Patronas; G Di Chiro; B H Smith; R De La Paz; R A Brooks; H L Milam; P L Kornblith; D Bairamian; L Mansi
Journal:  Brain Res       Date:  1984-01-16       Impact factor: 3.252

7.  Doppler perfusion index: an interobserver and intraobserver reproducibility study.

Authors:  K Oppo; E Leen; W J Angerson; T G Cooke; C S McArdle
Journal:  Radiology       Date:  1998-08       Impact factor: 11.105

8.  Crossed cerebellar hypoperfusion in hyperacute ischemic stroke.

Authors:  Masahiro Kamouchi; Masatoshi Fujishima; Yoshisuke Saku; Setsuro Ibayashi; Mitsuo Iida
Journal:  J Neurol Sci       Date:  2004-10-15       Impact factor: 3.181

9.  Crossed cerebellar diaschisis and brain recovery after stroke.

Authors:  B Infeld; S M Davis; M Lichtenstein; P J Mitchell; J L Hopper
Journal:  Stroke       Date:  1995-01       Impact factor: 7.914

10.  Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV.

Authors:  Arthur Varoquaux; Olivier Rager; Karl-Olof Lovblad; Karen Masterson; Pavel Dulguerov; Osman Ratib; Christoph D Becker; Minerva Becker
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-02-22       Impact factor: 9.236

View more
  8 in total

1.  Changes of fractional anisotropy and RGMa in crossed cerebellar diaschisis induced by middle cerebral artery occlusion.

Authors:  Yong Zhang; Xiao Wang; Jingliang Cheng; Yanan Lin; Lu Yang; Zhenghao Cao; Yunjun Yang
Journal:  Exp Ther Med       Date:  2019-09-09       Impact factor: 2.447

2.  Characteristics of cerebral perfusion and diffusion associated with crossed cerebellar diaschisis after acute ischemic stroke.

Authors:  Miao Zhang; Yanxiang Cao; Fang Wu; Cheng Zhao; Qingfeng Ma; Kuncheng Li; Jie Lu
Journal:  Jpn J Radiol       Date:  2019-11-13       Impact factor: 2.374

3.  Pathological factors contributing to crossed cerebellar diaschisis in cerebral gliomas: a study combining perfusion, diffusion, and structural MR imaging.

Authors:  Xiaoxue Liu; Jianrui Li; Qiang Xu; Dante Mantini; Peng Wang; Yuan Xie; Yifei Weng; Chiyuan Ma; Kangjian Sun; Zhiqiang Zhang; Guangming Lu
Journal:  Neuroradiology       Date:  2018-04-17       Impact factor: 2.804

4.  Remote effects in the ipsilateral thalamus and/or contralateral cerebellar hemisphere using FDG PET in patients with brain tumors.

Authors:  Hitomi Iwasa; Yoriko Murata; Miki Nishimori; Kana Miyatake; Michiko Tadokoro; Shino Kohsaki; Munenobu Nogami; Yusuke Ueba; Tetsuya Ueba; Takuji Yamagami
Journal:  Jpn J Radiol       Date:  2018-01-25       Impact factor: 2.374

5.  Crossed cerebellar hyperperfusion in patients with seizure-related cerebral cortical lesions: an evaluation with arterial spin labelling perfusion MR imaging.

Authors:  Jungho Won; Dae Seob Choi; Seok Jin Hong; Hwa Seon Shin; Hye Jin Baek; Ho Cheol Choi; Minjung Kim; Rock Bum Kim
Journal:  Radiol Med       Date:  2018-07-13       Impact factor: 3.469

6.  Detection of crossed cerebellar diaschisis in hyperacute ischemic stroke using arterial spin-labeled MR imaging.

Authors:  Koung Mi Kang; Chul-Ho Sohn; Seung Hong Choi; Keun-Hwa Jung; Roh-Eul Yoo; Tae Jin Yun; Ji-Hoon Kim; Sun-Won Park
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

7.  Crossed cerebellar diaschisis after acute ischemic stroke detected by intravoxel incoherent motion magnetic resonance imaging.

Authors:  Jianhong Ma; Lei Zhao; Kemei Yuan; Jingrui Yan; Yanbo Zhang; Jianzhong Zhu; Chengxin Yan
Journal:  Neurol Sci       Date:  2021-07-02       Impact factor: 3.307

8.  Crossed cerebellar diaschisis after stroke detected noninvasively by arterial spin-labeling MR imaging.

Authors:  Juan Wang; Li-Jun Pan; Bin Zhou; Jin-Yan Zu; Yi-Xu Zhao; Yang Li; Wan-Qiu Zhu; Lei Li; Jian-Rong Xu; Zeng-Ai Chen
Journal:  BMC Neurosci       Date:  2020-11-20       Impact factor: 3.288

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.